Educational Interventions for Recovery After Breast Cancer Treatment

KD
SS
Overseen BySheel Singh, MA
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: MGH Institute of Health Professions
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to determine the best way to promote participation in vocational, social, physical, and instrumental activities of daily living in people who have completed treatment for early stage breast cancer.

The main question it aims to answer is: Which of the intervention components, alone or in combination, most effectively promote participation in vocational, social, physical, and instrumental activities of daily living?

Participants will be asked to try one of 8 combination of three intervention components that have been shown to promote activity participation: (1) priority elicitation, (2) education, and (3) guided application involving goal setting, problem-solving and action planning.

Who Is on the Research Team?

KD

Kathleen D Lyons, ScD

Principal Investigator

MGH Institute of Health Professions

Are You a Good Fit for This Trial?

Inclusion Criteria

Experiencing reduced participation (i.e., a score of > 10 on the Work and Social Adjustment Scale)
I have Stage 1-3 breast cancer and finished treatment within the past year with no recurrence.
I am 18 years old or older.

Exclusion Criteria

I have hearing loss that cannot be corrected.
Moderate-severe cognitive impairment indicated by a score < 3 on a 6-item cognitive screener
History of severe mental illness (i.e., schizophrenia, bipolar disorder), current major depressive disorder, active suicidal ideation, or active substance misuse documented within the medical record
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Optimization Phase

Participants receive one of 8 combinations of intervention components to promote activity participation

20 weeks
Weekly telephone or videoconference sessions

Follow-up

Participants are monitored for satisfaction and ability to participate in social roles and activities

8 weeks
1 visit (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • Individually tailored education, Priority elicitation, Guided application

How Is the Trial Designed?

8

Treatment groups

Experimental Treatment

Group I: Priority elicitation, education, and guided applicationExperimental Treatment1 Intervention
Group II: Priority elicitation and guided applicationExperimental Treatment1 Intervention
Group III: Priority elicitation and educationExperimental Treatment1 Intervention
Group IV: Priority elicitationExperimental Treatment1 Intervention
Group V: InformationExperimental Treatment1 Intervention
Group VI: Guided applicationExperimental Treatment1 Intervention
Group VII: Education and guided applicationExperimental Treatment1 Intervention
Group VIII: EducationExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

MGH Institute of Health Professions

Lead Sponsor

Trials
19
Recruited
2,200+

University of South Alabama

Collaborator

Trials
44
Recruited
15,800+

Dartmouth-Hitchcock Medical Center

Collaborator

Trials
548
Recruited
2,545,000+

University of Alabama at Birmingham

Collaborator

Trials
1,677
Recruited
2,458,000+